High Gastrointestinal Carriage Rates of Extended-Spectrum-Β-Lactamase-Producing Enterobacterales and Associated Factors Among Hospitalized and Nonhospitalized Children in Kenya

dc.contributor.authorGithii, Susan
dc.contributor.authorNdungu, Cecilia
dc.contributor.authorMaingi, John M.
dc.contributor.authorMusyoki, Abednego
dc.date.accessioned2026-03-23T13:25:25Z
dc.date.available2026-03-23T13:25:25Z
dc.date.issued2025-03
dc.descriptionArticle
dc.description.abstractBackground: Gastrointestinal carriage of extended-spectrum β-lactamaseproducing Enterobacterales (ESBL-E) presents a critical public health threat globally. However, in resource-constrained countries with poor sanitation, inadequate drinking water, and limited microbiology laboratories like Kenya, epidemiological data of these strains is limited. This study assessed the gastrointestinal carriage of ESBL-E and the risk factors for colonization among children (≤ 5 years) in the inpatient department (IPD) and outpatient department (OPD). Method: This was a hospital-based cross-sectional study at Thika Level 5 Hospital, Kenya, from February to June 2023. In total, 540 participants (OPD: 270, IPD: 270) were recruited, using systematic random sampling and consecutive sampling in OPD and IPD, respectively. Children admitted for less than 48 hours in the paediatrics ward and those with a prior history of hospitalization (≤ 3 months) in OPD were excluded. Demographic data were collected using a well-structured questionnaire. Following the standard microbiology methods, stool or rectal swab samples were cultured, with the identity and antimicrobial susceptibility of isolates elucidated by automated platforms. Results: The overall ESBL-E gastrointestinal carriage rate was 35.4% (191/540), and was highest among outpatients at 40.4% (109/270). Isolates demonstrated co-resistance to aminoglycosides (43-52%), quinolones (52- 62%), carbapenems (44-50%), and sulfonamides (92-97%). They were more susceptible to piperacillin/tazobactam (67-95%) and colistin (96-99%). Carbapenemase-producing Enterobacterales (CPE) co-carriage rate was 17.6% (16/91), with similar rates for inpatients (50%, 8/16) and outpatients (50%, 8/16). Escherichia coli was the predominant ESBL-E overall (82.2%, 157/191), among outpatients (83.5%, 91/109), and inpatients (80.5%, 66/82), and was also the main CPE (overall: 81.3%, 13/16; OPD: 75%, 6/8; IPD: 87.5%, 7/8). Independent predictors of colonization included child age (adjusted odds ratio (OR): 1.60, p = 0.045) and a history of antimicrobial use from retail pharmacies without a clinician's prescription (adjusted OR: 0.18, p = 0.047). Conclusion: This study demonstrates a substantial burden of gastrointestinal carriage of ESBL-E and CPE co-carriage among children (≤ 5 years), with E. coli being the predominant organism. Age less than two years and a history of exposure to non-prescribed antimicrobials were independent factors for colonization. Efforts to limit exposure to contaminated environments and targeted antimicrobial stewardship initiatives are required to mitigate AMR in the current study setting.
dc.identifier.citationGithii, S., Ndungu, C., Maingi, J. M., & Musyoki, A. (2026). High gastrointestinal carriage rates of extended-spectrum-β-lactamase-producing enterobacterales and associated factors among hospitalized and nonhospitalized children in Kenya. Scientific Reports.
dc.identifier.urihttps://www.nature.com/articles/s41598-026-43265-6
dc.identifier.urihttps://ir-library.ku.ac.ke/handle/123456789/32834
dc.language.isoen
dc.publisherKenyatta University
dc.titleHigh Gastrointestinal Carriage Rates of Extended-Spectrum-Β-Lactamase-Producing Enterobacterales and Associated Factors Among Hospitalized and Nonhospitalized Children in Kenya
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Full-text Journal Article.pdf
Size:
900.97 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.66 KB
Format:
Item-specific license agreed upon to submission
Description: